Plasma Cell Disorder Monitoring System

Diagnostic testing solutions for continuous monitoring of chronic disease progression and management. Enables healthcare providers to track patient health status and treatment efficacy over time.

Diagnostic test designed for chronic disease monitoring and management. Enables regular assessment of disease markers to guide ongoing patient treatment.

Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.

Targeted sequencing panels designed for longitudinal patient monitoring and treatment response assessment. Enables detection of minimal residual disease and tracking of genomic changes over time to inform ongoing clinical management.

Multi-marker assessment including HbA1c, lipid profile, and cardiac markers for ongoing management of metabolic and cardiovascular conditions. Supports regular monitoring and treatment adjustment.

Point-of-care testing platform for monitoring anticoagulant and antiplatelet drug therapy. Enables individualized drug management and assessment of medication efficacy. Supports compliance monitoring in cardiovascular and cerebrovascular disease management.

POCT Chronic Disease Monitoring Systems enable rapid point-of-care testing for chronic disease management through colloidal gold and chemiluminescence immunoassay technologies. The platform supports multiple diagnostic test series including cardiac markers, biochemical parameters, and disease monitoring. Designed for clinical laboratories and healthcare facilities requiring quick, quantitative diagnostic results.

Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.

Sensitive detection of residual cancer cells following treatment through advanced molecular techniques. Provides early warning of disease recurrence in cancer patients.

A digital biomarker-based monitoring system designed for tracking disease progression and treatment response in musculoskeletal conditions. The platform enables objective, quantifiable follow-up assessments with reduced subjectivity and improved accessibility for patients with mobility limitations.

Therapeutic Drug Monitoring Control materials for clinical laboratory quality assurance across immunology and clinical chemistry platforms. Supports internal and external quality control processes with up to 3-year shelf life, compatible with all major analyzer brands and POCT devices. Enables real-time result tracking and performance comparison through DIQAS program integration.

Quality control products for therapeutic drug monitoring applications including immunosuppressant monitoring (cyclosporine, tacrolimus, sirolimus, everolimus) and pain management compliance monitoring. Supplied in 100% REAL human matrices including serum and whole blood in various forms.